1st Edition
Nanoparticles in Cancer Therapy Innovations and Clinical Applications
Part I: Nanoparticles in Cancer Vaccines and Gene Therapy
Chapter 1.1. Polymeric nanoparticles as nanovaccine carriers for eliciting anticancer immunity
Hardeep Kaur, Shinar Athwal, Sakshi Thakur, Prudhvilal Bhukya and Neelam Thakur
Chapter 1.2. Membrane-Based Nano-Vaccines for Immunotherapy
Harsha Sharma and Sakshi Thakur
Chapter 1.3. Gene Therapy Utilizing Nanoparticles
Radhika Jamwal
Part II: Advanced Nanomedicine Approaches
Chapter 2.1 From Diagnosis to Treatment: The Role of Chemodynamic Nanoparticles in Cancer Theranostics
Akriti Sharma, Arundhati, Manmeet Kaur, Vishal Sharma, Md Zia ul Haq andDisha Sharma Chapter 2.2 Low-Dimensional Nanomaterials as an Emerging Platform for Cancer Diagnosis and Therapy
Karan Mehta, Shamli Rajput and Surbhi Sharma
Chapter 2.3. Emerging Nano-based Strategies for Managing Drug Resistance in Cancer
Priyanka Chambial, Neelina Jaggarwal and Neelam Thakur
Chapter 2.4 Nanotechnology-based Radiation Therapy to Cure Cancer
Bhupender Sahu, Janvi Sharma, Bibhudendu Behera, Umesh Kumar
Chapter 2.5.Phototherapy Modalities Empowered by Nanotechnology
Nisha Kumari and Vishav Gaurav Singh Chandel
Chapter 2.6. Bioengineered Virus-Like Nanoparticles for Cancer Diagnostics and Therapeutics
Anupam Bhardwaj
Part III: Clinical Applications and Future Prospects
Chapter 3.1. Theranostic Nanoparticles: Revolutionizing Cancer Diagnosis and Treatment
Gagandeep Singh, Himanshu, Umesh Kumar and Neelam Thakur
Chapter 3.2.Anti-Cancer Nanotherapeutics in Clinical Trials: The Work Behind Clinical Translation of Nanomedicine
Priyanka Chambial, Neelam Thakur, L.Preethi and Pankaj Mehta
Chapter 3.3. Limitations of Cancer Nanotherapy: Present Status and Future Prospects
Navya Rana, Sunil Kumar and Ranjit Kumar
Chapter 3.4. Current Challenges and Future Prospects in Nanoparticle Application
Anuradha Derashri, Nitin Kolhe. Divya Dhawal Bhandari and Akanksha Dwivedi
Chapter 3.5. Assessment of Genotoxicity and Immunotoxicity Nanoparticles: Overview and testing methods
Rishabh Mittal, Aditi Agarwal, Shivashish Dobhal, Jitender Gairolla and
Manisha Naithani
Chapter 3.6.Assessment of Nanoparticles Induced Cytotoxicity and Safety Profiles
Devyani Rajput, Akanksha Dwivedi, Anuradha Derashri, Divya Dhawal Bhandari and Nitin Kolhe
Chapter 3.7. Nanotechnology in Cancer Therapy: Targeted Drug Delivery and the Role in Viral Oncogenesis
Darsh Gautam, Gaurav Joshi, Poonam Talwan and Preeti Bisht
Biography
Prudhvi Lal Bhukya is a Virologist currently serving at ICMR-National Animal Resource Facility for Biomedical Research (NARFBR), Hyderabad, as a Scientist. Presently, he is associated with the preclinical vaccine testing laboratory at NARFBR. His areas of work include preclinical vaccinology studies, hostviral interaction studies of emerging human viral infections, and the prevention and control of diseases, as well as the development of tools to prevent outbreaks. He obtained his Ph.D. from ICMR-National Institute of Virology, Pune, on human hepatitis B virus. He proved his credentials by working on HBV and HEV with an extensive publication record. He has presented his work at numerous national and international conferences and has received accolades with several publications in international journals like the Journal of General Virology, Journal of Virology, Journal of Travel Medicine, Indian Journal of Medical Microbiology and Science of Total Environment. He is an experienced manuscript writer and has contributed to several book chapters for publication bodies like Springer Nature, CRC Press, IntechOpen, IGI Global Publications, etc. Dr. Prudhvi also edited a book in Springer Nature entitled “Emerging Human Viral Disease” in two volumes. His contribution to these books as an editor will act as a catalyst, as his comments are highly critical and an achievement for the book.
Neelam Thakur is currently working as an Assistant Professor in the Department of Zoology at Sardar Patel University (a State Govt. University), Mandi, Himachal Pradesh, India since 2022. Before joining this university, she worked as an Associate Professor in the Department of Biosciences at Chandigarh University, Punjab, India. She obtained her Ph.D. in Genetics from Himachal Pradesh University in 2012. After her Ph.D., she joined as a Research Associate in the Immunology lab of CSIR-IMTECH, Chandigarh in 2012. Her research interests include the early diagnosis of tuberculosis and cancer, nanotechnology for cancer diagnostics and therapy, cytogenetic analysis of intellectually disabled individuals and microbiome studies. She has supervised many master’s students and is currently guiding Ph.D. students as well. She has published 18 research papers in journals with good impact factors, such as “Cellular Signaling”. Her patent, entitled “ANTIGENIC COMPOSITION AND METHOD OF EXPRESSION THEREOF”, was also published. She has received two Young Researchers Awards and one Eminent Researchers Award from government-registered societies/ organizations for her contribution to research.
